You’ve noticed your once-energetic kid suddenly seems tired all the time. They’re chugging water like they just ran a marathon, even in winter. And those middle-of-the-night bathroom trips? They’re ...
Cases of childhood diabetes continue to rise across the country, affecting both younger children and adolescents. Early detection can significantly impact a child’s health trajectory, making awareness ...
Family history raises diabetes risk but does not guarantee it. Healthy lifestyle choices can prevent or delay type 2 diabetes ...
Childhood diabetes is an increasing global health challenge, according to a study published online July 3 in JAMA Pediatrics. Kexin Zhang, from Affiliated Hospital of Weifang Medical University in ...
New study reveals alarming trends in childhood diabetes rates, urging global action to tackle socioeconomic disparities and prevent a growing public health crisis. Study: Updated Insights on Childhood ...
Screening children for type 1 diabetes-associated islet autoantibodies at ages 2 years and 6 years would identify most of those who go on to develop the condition by mid-adolescence, new data suggest.
A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is effective, laying the groundwork for a UK-wide childhood screening program.
Type 1 diabetes usually begins in children and young adults, but it can happen at any age. For those who are undiagnosed, the ...
Much attention has focused on the increasing prevalence of childhood type 2 diabetes mellitus. However, considerable evidence suggests that the incidence of childhood type 1 diabetes mellitus is also ...
Diabetes was earlier considered as a disorder that was associated with adulthood. But, the number of children who are being ...
The NHS begins offering teplizumab, the first drug shown to delay type 1 diabetes and postpone insulin by nearly three years.
Eli Lilly Canada announced today that Mounjaro® (tirzepatide), the first and only Health Canada-authorized once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...